1. Home
  2. FBGL vs NCEL Comparison

FBGL vs NCEL Comparison

Compare FBGL & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FBGL

FBS Global Limited Ordinary Shares

HOLD

Current Price

$1.09

Market Cap

11.3M

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.65

Market Cap

12.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBGL
NCEL
Founded
1996
2008
Country
Singapore
Switzerland
Employees
N/A
11
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
12.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FBGL
NCEL
Price
$1.09
$2.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.9M
47.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.89
52 Week High
$1.20
$4.70

Technical Indicators

Market Signals
Indicator
FBGL
NCEL
Relative Strength Index (RSI) 63.45 47.36
Support Level $0.53 $2.44
Resistance Level $1.14 $3.19
Average True Range (ATR) 0.10 0.20
MACD 0.01 -0.01
Stochastic Oscillator 68.05 8.27

Price Performance

Historical Comparison
FBGL
NCEL

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: